A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer
Số trang: 6
Loại file: pdf
Dung lượng: 528.35 KB
Lượt xem: 7
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
We aimed to evaluate the efficacy and safety of nab-paclitaxel in patients with refractory advanced non-small cell lung cancer who failed previous chemotherapy.
Nội dung trích xuất từ tài liệu:
A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer
Nội dung trích xuất từ tài liệu:
A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Lung cancer Nab-paclitaxel Non-small cell lung cancer Third-line therapyGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 167 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 139 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 109 0 0 -
12 trang 87 0 0
-
19 trang 72 0 0
-
17 trang 60 0 0
-
9 trang 35 0 0
-
11 trang 35 0 0
-
12 trang 33 0 0